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INTRODUCTION 
Glioblastoma multiforme (GBM) cells display a highly invasive phenotype, a hallmark which counters 
effective surgical and radiotherapy strategies. Caveolin-1 (Cav-1) is the main structural and 
functional component of caveolae. The impact of the expression of Cav-1 within a range of tumour 
and tumour-associated stromal cells is variable with both oncogenic and tumour suppressive roles 
reported which appear to be both disease-specific and context-dependent. Our hypothesis is that 
Cav-1 serves as promoter of invasion of GBM cells. 
MATHERIALS AND METHODS 
To investigate our hypothesis we used a lentiviral shRNA approach to silence Cav-1 in three GBM cell 
lines (U87, UP007, UP029) derived from adult brain tumours. We employed an in-vitro 3D cell-
sprouting invasion assay with GBM cell spheres embedded in Matrigel. Quantification of invasion 
was undertaken using a novel image analysis tool or 3D systems, INSIDIA (ImageJ Macro for High-
throughput Spheroid Invasion Analysis). Parallel migration and invasion studies were performed 
using a Boyden Chamber approach, as well as cell-cell adhesion assays. Activation of signalling 
pathways in 2D and 3D cultures were performed by proteomic array and Western Blot analysis. 
RESULTS AND CONCLUSION 
GBM cells expressing Cav-1 (Cav-1 +ve) displayed a higher invasive capacity compared cells where 
Cav-1 had been silenced Cav-1 –ve), the latter also showing increased cell-cell adhesion. A significant 
finding from the signalling analysis was an inverse association between Cav-1 silencing and 
activation of AKT evidenced by increased phosphorylation at both Ser473 and Thr308 sites. Ongoing 
studies are exploring this signalling axis and its relationship to the invasive phenotype. 
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